Industry

DUBLIN–(BUSINESS WIRE)–The “Global Kidney Cancer Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global kidney cancer market is anticipated to grow at a substantial CAGR of 6.2% during the forecast period. As per the American Cancer Society, kidney cancer is among the 10 most common cancers in both men and women. Overall, the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Imaging Market Size, Share & Trends Analysis Report by Services (Clinical Trial Design and Consultation Services, Reading and Analytical Services), by End Use, by Application, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global clinical trial imaging market is expected to reach USD 1.97 billion … [Read more…]

SHENZHEN, China–(BUSINESS WIRE)–International scientists led by China’s BGI•Research released the world’s first panoramic spatial atlases of life on May 4, examining the cellular dynamics of organisms at different developmental stages and providing potentially significant new information for disease treatment, development and aging, and an improved understanding of biological evolution. In a series of studies published … [Read more…]

– AuriNovo™ an investigational, 3D-bioprinted implant was created using a proprietary process leveraging the patient’s own tissue to generate an implantable ear – – Phase 1/2a clinical trial enrolling patients with microtia, a rare congenital disorder where reconstruction options are limited – – AuriNovo™ granted Orphan Drug and Rare Pediatric Disease Designations by the U.S. … [Read more…]

Mittelstand companies face inevitable uncertainty, business challenges and rising geopolitical tensions head-on in the year ahead FRANKFURT, Germany–(BUSINESS WIRE)–Nearly all (95%) German Mittelstand leaders expect business repercussions from the war in Ukraine for at least six months, up 14% from March, citing higher energy prices (50%), commodity prices (47%) and inflation (38%) as the top … [Read more…]

KYOTO, Japan–(BUSINESS WIRE)–Megakaryon Corporation (hereinafter, Megakaryon) today announces its clinical trial of allogenic human iPSC-derived HLA homozygous platelets (Development Code: MEG-002) in collaboration with Kyoto University Hospital, Center for iPS Cell Research and Application, Kyoto University (CiRA) and CiRA Foundation (CiRA_F). Initial administration to the first subject was successful and with no reported adverse events. … [Read more…]

LARGO, Fla.–(BUSINESS WIRE)–CONMED Corporation (NYSE: CNMD) today announced the pricing of $700 million aggregate principal amount of 2.25% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering of the notes, CONMED … [Read more…]

BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced that it will participate in and present at the Jefferies Global Healthcare Conference 2022 on Friday, June 10, 2022 at 12:45 PM ET. A live webcast … [Read more…]

LEXINGTON, Mass.–(BUSINESS WIRE)–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $4.75 per share. The gross proceeds to Concert, before deducting underwriting discounts and commissions and estimated offering expenses payable by Concert, are expected to be approximately … [Read more…]

BROOKLYN, N.Y.–(BUSINESS WIRE)–Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AC0176 for the treatment of patients with metastatic castration resistant prostate cancer (mCRPC) with disease progression on or after treatment with androgen … [Read more…]